Mental Health Research Grants
Open Opportunities (45)
Live Grants.gov opportunities funded under this program — you can apply now.
- Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research Deadline: Jun 9, 2026 · up to $2M
- Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC) (U24 Clinical Trial Not Allowed) Deadline: Jun 9, 2026 · up to $5M
- Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed) Deadline: Jun 10, 2026
- BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) Deadline: Jun 24, 2026
- Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) Deadline: Sep 7, 2026
- Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) Deadline: Sep 7, 2026
- Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) Deadline: Sep 7, 2026
- Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) Deadline: Sep 7, 2026
- Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) Deadline: Sep 7, 2026
- Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) Deadline: Sep 7, 2026
- Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer’s Dementia (R01 Clinical Trial Optional) Deadline: Sep 7, 2026
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) Deadline: Oct 1, 2026
- Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required) Deadline: Oct 11, 2026
- Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and Risks Deadline: Oct 22, 2026
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer’s Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Require Deadline: Nov 19, 2026
- Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) Deadline: Jan 7, 2027
- Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) Deadline: Jan 7, 2027 · up to $250K
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) Deadline: Feb 11, 2027 · up to $700K
- Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) Deadline: Apr 9, 2027 · up to $200K
- Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers Deadline: May 27, 2027
- BRAIN Initiative: Data Archives for the BRAIN Initiative Deadline: Jun 1, 2027
- First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required) Deadline: Oct 15, 2027
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) Deadline: Oct 15, 2027
- Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required) Deadline: Oct 15, 2027
- Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) Deadline: Oct 15, 2027
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) Deadline: Oct 15, 2027
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) Deadline: Oct 15, 2027
- Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) Deadline: Oct 15, 2027
- Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 – Clinical Trial Required) Deadline: Oct 15, 2027
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) Deadline: Oct 15, 2027
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional) Deadline: Oct 25, 2027
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional) Deadline: Oct 25, 2027
- Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required) Deadline: Jan 7, 2028
- Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) Deadline: Jan 7, 2028
- Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required) Deadline: Jan 7, 2028
- Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) Deadline: Jan 7, 2028
- Laboratories to Optimize Digital Health (R01 Clinical Trial Required) Deadline: Jan 7, 2028
- Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) Deadline: Jan 7, 2028
- Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) Deadline: Jan 7, 2028
- Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) Deadline: Jan 7, 2028 · up to $225K
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) Deadline: Jan 7, 2028
- Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) Deadline: Jan 7, 2028
- Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) Deadline: Jan 7, 2028
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) Deadline: Jan 7, 2028 · up to $200K
- Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) Deadline: Jan 7, 2028
Program Funding
Annual program obligations reported to SAM.gov.
Who has received this funding
Organizations awarded under CFDA 93.242 (USAspending.gov).
- Allen Institute 2 awards $139,761,367
- Yale Univ 2 awards $107,321,544
- Salk Institute For Biological Studies, San Diego, California, The $74,756,329
- Cold Spring Harbor Laboratory $63,991,707
- The Broad Institute, Inc $54,214,022
- Regents Of The University Of California, San Francisco, The $38,895,082
- University Of California, Los Angeles $38,475,557
- Research Foundation For Mental Hygiene, Inc. $34,635,977
Program Objective
The mission of the National Institute of Mental Health (NIMH) is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure.
We fulfill this mission by supporting and conducting research on mental illnesses, health services, and the underlying basic science of the brain and behavior; supporting the training of scientists to carry out basic and clinical mental health research; and communicating with scientists, patients, providers, and the public about mental health research advances and priorities.
In May 2024, NIMH released its Strategic Plan for Research. The Strategic Plan builds on the successes of previous NIMH strategic plans by providing a framework for scientific research and exploration, and addressing new challenges in mental health.
The new Strategic Plan outlines four high-level Goals:
• Goal 1: Define the Brain Mechanisms Underlying Complex Behaviors
• Goal 2: Examine Mental Illness Trajectories Across the Lifespan
• Goal 3: Strive for Prevention and Cures
• Goal 4: Strengthen the Public Health Impact of NIMH-Supported Research
These four Goals form a broad roadmap for the Institute’s research priorities over the next five years, beginning with the fundamental science of the brain and behavior, and extending through evidence-based services that improve public health outcomes.
Eligibility
Eligible Applicants
- Local
- State
- Territorial
- Tribal
- Foreign Nonprofit Organization
- Foreign Not-for-Profit Organization
- Foreign For-Profit Organization
- International Organization
- Nonprofit Organization
- Not-for-Profit Organization
- Small Business Person
Public, private, -profit, or nonprofit agencies (including State and local government agencies), eligible Federal agencies, universities, colleges, hospitals, and academic or research institutions may apply for research grants. SBIR grants can be awarded only to domestic small businesses, and STTR grants can be awarded only to domestic small businesses which "partner" with a research institution in cooperative research and development.
An applicant for individual predoctoral fellowship support must be enrolled in a research doctoral degree program by the proposed activation date of the fellowship. A postdoctoral applicant must have received a Ph.D., Psy.D., M.D., D.D.S., Sc.D., D.N.S., D.O., D.S.W., or equivalent degree from an accredited institution to be eligible for an individual postdoctoral fellowship.
All research training awards are made to appropriate domestic research centers, medical schools, departments of psychiatry, non-medical academic departments, psychiatric hospitals or hospitals with psychiatric services, community mental health centers, and biomedical research institutes on behalf of individuals who need the opportunity to realize research potential. Except for the NIH Pathway to Independence (PI) Award (K99/R00), the individuals must be citizens or nationals of the United States or have been lawfully admitted for permanent residence. The NIH Pathway to Independence (PI) Award (K99/R00) is open to both U.S. citizens and non-U.S. citizens. Individuals must qualify by scholastic degree and previous training and/or experience.
How to Apply
Award Procedure
All applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel. Applications other than fellowships must also be reviewed by the National Advisory Mental Health Council . All competitive applications compete for available funds on the basis of scientific and technical merit, program relevance, and program balance. All SBIR and STTR applications receiving a priority score compete for set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.
Decision Timeline
- Approval: > 180 Days
Applications: From 180 to 270 days from submission of application.
SBIR/STTR applications: About 7- 12 months;
AIDS-related research is expedited and a determination is made within 180 days.
Program details & compliance
Description
The mission of the National Institute of Mental Health (NIMH) is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure.
Mission Categories
Primary: Mental Health
Other categories:
BiologyResearch and DevelopmentSocial SciencesPrevention and Control (includes Suicide Prevention)
Use of Funds
Allowed Uses
Research project grants provide support for clearly defined projects by a named investigator in an area representing his/her specific interests and competencies. Exploratory/Development and Clinical Exploratory/Developmental Grants encourage the development of new research activities in categorical program areas. Small Research Grants provide research support specifically limited in time and amount for studies in categorical program areas. Collaborative Clinical Research Grants support evaluations of various methods of therapy and/or prevention. Program Project and Center grants support large-scale, broad-based programs of research, usually interdisciplinary, consisting of several projects with a common focus. Cooperative Agreements support single or a group of related research activities with greater involvement of federal staff.
SBIR and STTR grants are awarded in two stages: Phase I grants are awarded to establish the technical merit and feasibility of a proposed research and development effort; only Phase I awardees are eligible to receive Phase II support.
Mentored Research Scientist Development Award (K01, MRSDA), Mentored Clinical Scientist Development Award (K08, MCSDA), and Mentored Quantitative Research Career Development Award (K25) provide support for individuals with research potential who need additional mentored development and/or experience in a productive research environment. Mentored Patient-Oriented Research Career Development Award (K23) supports the career development of individuals who have made commitment to focus their research endeavors on patient-oriented research. The NIH Pathway to Independence (PI) Award (K99/R00) provides up to 2 years of mentored support (K99) for a postdoctoral individual followed by up to 3 years of support after the awardee transitions to research independence (R00). K99/R00 awards are awards for up to 5 years of support. Salary support for all mentored awards may be supplemented by the sponsoring institution from nonfederal funds. The Independent Scientist Award (K02, ISA) is for independent scientists whose careers are developing rapidly; the Mid-career Investigator Award in Patient-Oriented Research (K24) is for outstanding clinical scientists engaged in patient-oriented research. No specialized training costs are available; limited research costs for K24s and K02s in theoretical areas are available.
NRSA awards: Individual fellowships are made to students seeking predoctoral or postdoctoral support for full-time research training or who are enrolled in an formal Ph.D. or M.D./Ph.D. program. An institutional allowance will be provided to the sponsoring institution for each awardee. In addition, any domestic public or nonprofit institution may apply for an institutional research training grant in a specified area of research from which a number of stipend awards will be made to individuals selected by the training program director at the institution. Support is available for both predoctoral and postdoctoral trainees and will include an amount for institutional expenses. Indirect costs may be requested at 8 percent of total direct costs, exclusive of tuition and related fees and expenditures for equipment, or actual indirect costs, whichever is less. Postdoctoral students receiving fellowships or stipend support under either individual or institutional grants for 12 months or less are obligated to pay back this support through an equivalent period of continued postdoctoral training or a period of health related research and/or teaching activities after the completion of their training. Postdoctoral individuals in their thirteenth and subsequent months of support will incur no further obligation, and such support will be considered acceptable postdoctoral payback service. Research training support may not be used for internships or other clinical training.
Required Documentation
For-profit organizations' costs will be determined in accordance with 48 CFR, Subpart 31.2 of the Federal Acquisition Regulations. For all other grantees, costs will be determined in accordance with HHS Regulations 45 CFR 75. For SBIR and STTR grants, applicant organization (small business concern) must present in a research plan an idea that has potential for commercialization and furnish evidence that scientific competence, experimental methods, facilities, equipment, and funds requested are appropriate to carry out the plan. Instructions for electronic submission may be found with the federal SF424 (R&R) form packages that are found in the SBIR/STTR funding opportunity announcements. Instructions are provided for SBIR Phase I and Phase II awards, respectively; as well as for STTR Phase I and Phase II awards, respectively.
The cost principles for awards under this program are set forth in HHS regulations at 45 CFR 75, Subpart E and Appendix IX (hospitals) to Part 75. Commercial organizations are subject to the cost principles located at 48 CFR 31.2 Federal Acquisition Regulation. See the NIH Grants Policy Statement for further guidance on the applicability of cost principals (http://grants.nih.gov/grants/policy/nihgps/index.htm).
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements